BRIEF-Berkshire Hathaway Not In The Market To Buy A Train Company

BRIEF-Berkshire Hathaway Not In The Market To Buy A Train Company - CNBC

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Berkshire Hathaway Not In The Market To Buy A Train Company - CNBC

Aug 25, 2025 10:37 AM

Aug 25 (Reuters) -

* BERKSHIRE HATHAWAY NOT IN THE MARKET TO BUY A TRAIN

COMPANY -

CNBC

Source text: https://tinyurl.com/yc5bz4nc

Further company coverage:

Previous page： --GM CFO Says Company Must Consider Moving Plants if Tariffs Are Permanent, Reuters Reports Next page： Wix Full-Year Revenue, Bookings Guidance Misses Estimates; Fourth-Quarter Earnings Top Views

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--GM CFO Says Company Must Consider Moving Plants if Tariffs Are Permanent, Reuters Reports

Feb 19, 2025

10:28 AM EST, 02/19/2025 (MT Newswires) -- Price: 47.75, Change: -0.38, Percent Change: -0.79 ...

Wix Full-Year Revenue, Bookings Guidance Misses Estimates; Fourth-Quarter Earnings Top Views

Feb 19, 2025

10:28 AM EST, 02/19/2025 (MT Newswires) -- Wix.com ( WIX ) reported stronger-than-expected fourth-quarter earnings on Wednesday, but the Israeli software company's full-year outlook for revenue and bookings came in below market estimates. The firm, which provides cloud-based web development services, posted adjusted earnings of $1.93 a share for the December quarter, up from $1.22 the year before. The consensus...

Lifeward CEO to Retire; 2024 Revenue Guidance Updated

Feb 19, 2025

10:28 AM EST, 02/19/2025 (MT Newswires) -- Lifeward ( LFWD ) said Wednesday its Chief Executive Larry Jasinski will retire in Q2. The company said a special committee will lead the search for a new CEO, considering internal and external candidates. Lifeward ( LFWD ) said it is postponing its Feb. 20 investor event until after a new CEO is...

CNS Pharmaceuticals to Implement 1-for-50 Reverse Stock Split; Shares Down

Feb 19, 2025

10:27 AM EST, 02/19/2025 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement. The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday. Shares of CNS Pharmaceuticals...